RECRUITING

Remote Patient Monitoring and Health Coaching vs. Usual Care for the Treatment of Hypertension

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

High blood pressure, also known as hypertension, affects nearly half of all Americans and increases the risk for heart disease and stroke. Only about half of people with high blood pressure have it under control. New methods to control blood pressure are needed to reduce heart attack and stroke rates. The purpose of this study is to test whether a digital program that includes personalized health coaching and remote patient monitoring with a connected blood pressure cuff, all delivered on a smartphone or website, can improve blood pressure control compared with usual care among patients with high blood pressure.

Official Title

A Pragmatic RCT of Remote Patient Monitoring and Health Coaching vs. Usual Care for the Treatment of Hypertension

Quick Facts

Study Start:2022-07-29
Study Completion:2026-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05394766

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Clinical diagnosis of hypertension
  2. * 18+ years of age
  3. * English-speaking
  4. * Receives primary care at Stanford Primary Care
  1. * \<18 years of age
  2. * Primary language not English
  3. * Active or prior enrollment in Omada Program

Contacts and Locations

Study Contact

Steven Lin, MD
CONTACT
6507257966
stevenlin@stanford.edu

Principal Investigator

Steven Lin, MD
PRINCIPAL_INVESTIGATOR
Stanford University

Study Locations (Sites)

Stanford University
Redwood City, California, 94063
United States

Collaborators and Investigators

Sponsor: Stanford University

  • Steven Lin, MD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-07-29
Study Completion Date2026-07

Study Record Updates

Study Start Date2022-07-29
Study Completion Date2026-07

Terms related to this study

Additional Relevant MeSH Terms

  • Hypertension